Albertsons Companies Q4 Highlights: 5% Sales Growth, Earnings Beat, Difficult Consumer Environment & More

  • Albertsons Companies Inc ACI reported fourth-quarter FY22 sales growth of 5.1% year-on-year, to $18.27 billion, beating the consensus of $18.22 billion. Identical sales increased 5.6%, and digital sales rose 16%.
  • Gross margin rate contracted 90 basis points to 27.8%, with the pharmacy business driving approximately half of the rate decrease, reflecting fewer COVID-19 vaccinations.
  • The company administered 0.4 million COVID-19 vaccinations during the fourth quarter, compared to 2.3 million in the year-ago quarter.
  • Operating margin was 2.4%, and operating income for the quarter fell 34.7% to $433.6 million.
  • The company held $463.8 million in cash and equivalents as of Feb. 25, 2023.
  • Adjusted EBITDA of $1.1 billion fell 2.2% Y/Y. Adjusted EPS of $0.79 beat the analyst consensus of $0.67.
  • The number of stores at the end of the quarter was 2,271. Inventories at the end of the quarter totaled $4.8 billion.
  • The company's Board has declared a cash dividend for the first quarter of fiscal 2023 of $0.12 per share, payable on May 10, 2023, to stockholders of record on Apr. 26, 2023.
  • "We expect further declines in Covid-19 vaccination and at-home test kit revenue," said CEO Vivek Sankaran.
  • The company expects significant labor investments and inflationary cost increases going ahead.
  • RelatedKroger, Albertsons Finally Seal The Rumored Merger Deal: See Highlights
  • Price Action: ACI shares are trading lower by 1.34% at $20.92 on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsDividendsGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!